BackgroundImmunotherapy combined with chemotherapy has improved outcomes in advanced gastric cancer (GC), but reliable biomarkers to predict clinical benefit remain limited. Metabolomics provides a co
Supplemental material, sj-xlsx-5-dhj-10.1177_20552076231169846 for An integrated targeted metabolomics and network pharmacology approach to exploring the mechanism of ellagic acid against sleep depriv
